Wilson Sonsini Goodrich & Rosati advised GC Therapeutics on the transaction. GC Therapeutics (GCTx), a biopharmaceutical company, announced its launch and the completion of a $65...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here